Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Senate Democrats Meet With White House Adviser To Craft Response To Republican Criticism On Health Reform
Senate Democrats on Wednesday worked with senior White House adviser David Axelrod to craft a health care message focused on affordability and choice, the AP/Contra Costa Times reports (Werner, AP/Contra Costa Times, 5/13). The meeting followed the release of a memo last week by Republican strategist Frank Luntz outlining how to criticize Democratic plans for health reform (Budoff Brown/McGrane, Politico, 5/13). Senate Majority Whip Richard Durbin (D-Ill.) said Luntz"s memo was "an interesting catalyst for us" (AP/Contra Costa Times, 5/13).Axelrod presented Democrats with polling data about what U.S. residents are seeking from a health care overhaul and discussed better word choices, such as "shared responsibility" rather than "mandates" for coverage requirements. According to CongressDaily, the meeting centered Democrats on a coordinated message that the U.S. health care system must be affordable and accessible and should be patient-focused (Edney/Condon, CongressDaily, 5/13). Sen. Evan Bayh (D-Ind.) said that many Democrats felt "unease that we did not have a strategy" to answer the attacks coming from Republicans (Pear, New York Times, 5/14). Senate Finance Committee Chair Max Baucus (D-Mont.) said, "Everybody in the room had been a little nervous that, "Gee, Democrats don"t have their act together"" (CongressDaily, 5/13). However, Bayh said that "Axelrod came to reassure us that they do have a strategy" (New York Times, 5/14). Durbin said, "This is an effort to coordinate our message so we present a health care reform effort the American people trust" (Armstrong, CQ Today, 5/13). According to Durbin, Axelrod emphasized that Democrats should continue with the campaign theme that the goal of an overhaul is to "fix what"s broken in the system and preserve what"s good" (Young, The Hill, 5/13).Sen. Charles Schumer (D-N.Y.) said, "We believe the public shares our views. But we don"t want to be overwhelmed by either res, messaging or boots on the ground." He added, "We won"t make the mistake of 1993-94." According to the New York Times, a plan developed by the administration of former President Clinton "collapsed" in the face of Republican criticism (New York Times, 5/14).
generic viagra online
'Gender Gap' In Authorship Of Psychiatric Research
Less than a quarter of psychiatric research papers published in medical journals have a female first author, according to new research presented at the Royal College of Psychiatrists" 2009 Annual Meeting.
News of the day
Regulation Must Be Extended To Help Stamp Out Abuse, UK
Patients will continue to be unprotected if statutory independent regulation is not extended to counsellors and psychotherapists, according to leading national charities Mind and WITNESS. On the day that psychologists are to be regulated by the Health Professions Council (HPC), the charities welcome the advancement and urge counsellors and psychotherapists to follow suit.
Health Insurance

Inconclusive Research Links Glargine Insulin (Lantus) With Cancer

Diabetes UK has today cautioned that research claiming there is a link between certain insulins and some cancers is "inconclusive". Results of four studies looking at the risk of cancer largely in people with Type 2 diabetes treated with insulin, particularly glargine insulin (Lantus), were published in Diabetologia - the Journal of the European Association for the Study of Diabetes - last week. The studies were based in Germany, Sweden, Scotland and the UK. The data of around 300,000 people treated with insulin was reviewed in the studies, of which 34,392 were taking glargine insulin (Lantus) alone. The German study suggested there may be a small increased risk of cancer in those taking glargine as their only insulin; with the strongest link seeming to be with breast cancer in older people. This small increase in risk appeared in two of the other three studies and seemed to be more so in people on high doses. Sir Professor George Alberti, Chairman of Diabetes UK, said: "It should be stated firmly that the evidence in these studies is not conclusive and that there are limitations with the research. "People with diabetes who are using glargine insulin should continue to take their medication as prescribed. You will become very ill if you stop taking your insulin. If you are concerned about these findings then you should speak to your healthcare team about your anxieties before discontinuing any treatment." Diabetes UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009